| Filed On | Filing |
|---|---|
| 03 Aug 2022 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
GAITHERSBURG, Md., August 1, 2022—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2022. |
| 09 Sep 2021 | 8-K/A: Financial Statements and Exhibits |
| 01 May 2020 | 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 12 Dec 2018 | 8-K/A: Financial Statements and Exhibits |
| 12 Dec 2018 | 8-K/A: Financial Statements and Exhibits |
| 12 Dec 2013 | 8-K/A: Regulation FD Disclosure |
| 13 Jan 2011 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 16 Aug 2010 | 8-K/A: Other Events |
| 23 Oct 2007 | 8-K/A: Results of Operations and Financial Condition |
Loading...
